Harvey-White J - Search Results

1

Differential inhibition of neuronal and extraneuronal monoamine oxidase.

Eisenhofer G, Lenders JW, Harvey-White J, Ernst M, Zametkin A, Murphy DL, Kopin IJ. Eisenhofer G, et al. Neuropsychopharmacology. 1996 Sep;15(3):296-301. doi: 10.1016/0893-133X(95)00233-4. Neuropsychopharmacology. 1996. PMID: 8873113

2

Assessment of brain dopamine metabolism from plasma HVA and MHPG during debrisoquin treatment: validation in monkeys treated with MPTP.

Kopin IJ, Bankiewicz KS, Harvey-White J. Kopin IJ, et al. Neuropsychopharmacology. 1988 May;1(2):119-25. doi: 10.1016/0893-133x(88)90003-6. Neuropsychopharmacology. 1988. PMID: 3266957

3

Effect of MPTP-induced parkinsonism in monkeys on the urinary excretion of HVA and MHPG during debrisoquin administration.

Kopin IJ, Bankiewicz K, Harvey-White J. Kopin IJ, et al. Life Sci. 1988;43(2):133-41. doi: 10.1016/0024-3205(88)90290-1. Life Sci. 1988. PMID: 3260652

4

Increased striatal dopamine production from L-DOPA following selective inhibition of monoamine oxidase B by R(+)-N-propargyl-1-aminoindan (rasagiline) in the monkey.

Finberg JP, Wang J, Bankiewicz K, Harvey-White J, Kopin IJ, Goldstein DS. Finberg JP, et al. J Neural Transm Suppl. 1998;52:279-85. doi: 10.1007/978-3-7091-6499-0_28. J Neural Transm Suppl. 1998. PMID: 9564628

5

Differential effects of chemical sympathectomy on expression and activity of tyrosine hydroxylase and levels of catecholamines and DOPA in peripheral tissues of rats.

Kawamura M, Schwartz JP, Nomura T, Kopin IJ, Goldstein DS, Huynh TT, Hooper DR, Harvey-White J, Eisenhofer G. Kawamura M, et al. Neurochem Res. 1999 Jan;24(1):25-32. doi: 10.1023/a:1020919828028. Neurochem Res. 1999. PMID: 9973233

6

Effect of glipizide on dopamine synthesis, release and metabolism in PC12 cells.

Lamensdorf I, He L, Nechushtan A, Harvey-White J, Eisenhofer G, Milan R, Rojas E, Kopin IJ. Lamensdorf I, et al. Eur J Pharmacol. 2000 Jan 28;388(2):147-54. doi: 10.1016/s0014-2999(99)00839-0. Eur J Pharmacol. 2000. PMID: 10666506

7

Metabolic stress in PC12 cells induces the formation of the endogenous dopaminergic neurotoxin, 3,4-dihydroxyphenylacetaldehyde.

Lamensdorf I, Eisenhofer G, Harvey-White J, Hayakawa Y, Kirk K, Kopin IJ. Lamensdorf I, et al. J Neurosci Res. 2000 May 15;60(4):552-8. doi: 10.1002/(SICI)1097-4547(20000515)60:4<552::AID-JNR14>3.0.CO;2-U. J Neurosci Res. 2000. PMID: 10797558

8

3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells.

Lamensdorf I, Eisenhofer G, Harvey-White J, Nechustan A, Kirk K, Kopin IJ. Lamensdorf I, et al. Brain Res. 2000 Jun 23;868(2):191-201. doi: 10.1016/s0006-8993(00)02309-x. Brain Res. 2000. PMID: 10854571

9

Brain MRI, lumbar CSF monoamine concentrations, and clinical descriptors of patients with spinocerebellar ataxia mutations.

Higgins JJ, Harvey-White JD, Nee LE, Colli MJ, Grossi TA, Kopin IJ. Higgins JJ, et al. J Neurol Neurosurg Psychiatry. 1996 Dec;61(6):591-5. doi: 10.1136/jnnp.61.6.591. J Neurol Neurosurg Psychiatry. 1996. PMID: 8971105 Free PMC article.

10

Acidic dopamine metabolites are actively extruded from PC12 cells by a novel sulfonylurea-sensitive transporter.

Lamensdorf I, Hrycyna C, He LP, Nechushtan A, Tjurmina O, Harvey-White J, Eisenhofer G, Rojas E, Kopin IJ. Lamensdorf I, et al. Naunyn Schmiedebergs Arch Pharmacol. 2000 Jun;361(6):654-64. doi: 10.1007/s002100000246. Naunyn Schmiedebergs Arch Pharmacol. 2000. PMID: 10882041

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters